141 related articles for article (PubMed ID: 36951881)
1. Johnston RL, Mottok A, Chan FC, et al. A gene expression-based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma. Blood. 2022;139(6):889-893.
Blood; 2023 Mar; 141(12):1495. PubMed ID: 36951881
[No Abstract] [Full Text] [Related]
2. Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
Skinnider BF; Elia AJ; Gascoyne RD; Trümper LH; von Bonin F; Kapp U; Patterson B; Snow BE; Mak TW
Blood; 2001 Jan; 97(1):250-5. PubMed ID: 11133768
[TBL] [Abstract][Full Text] [Related]
3. The real risk of secondary non-Hodgkin lymphoma following classical Hodgkin lymphoma.
Dogan A
Haematologica; 2023 May; 108(5):1220-1221. PubMed ID: 36263845
[No Abstract] [Full Text] [Related]
4. The spectrum of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a description of 10 cases.
Gualco G; Natkunam Y; Bacchi CE
Mod Pathol; 2012 May; 25(5):661-74. PubMed ID: 22222636
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of Hodgkin's disease: an update on histopathological and immunophenotypical features.
Fraga M; Forteza J
Histol Histopathol; 2007 Aug; 22(8):923-35. PubMed ID: 17503349
[TBL] [Abstract][Full Text] [Related]
6. [Cytogenetics of malignant lymphoma].
Fonatsch C
Internist (Berl); 1993 Feb; 34(2):114-8. PubMed ID: 8454423
[No Abstract] [Full Text] [Related]
7. EOMES/TBET and soluble CTLA4/full length CTLA4 expression ratios impact on the therapeutic response in patients with classical Hodgkin lymphoma.
Vera-Lozada G; Barros MHM; Alves P; Segges P; Land MGP; Hassan R
Br J Haematol; 2019 Mar; 184(6):1061-1064. PubMed ID: 29741770
[No Abstract] [Full Text] [Related]
8. Case report: Composite mantle cell lymphoma and classical Hodgkin lymphoma.
Wang H; Yang L; Li Q; Song H; Ji H
Pathol Oncol Res; 2023; 29():1611051. PubMed ID: 37006439
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric analysis of CD123 is useful for immunophenotyping classical Hodgkin lymphoma.
Fromm JR
Cytometry B Clin Cytom; 2011 Mar; 80(2):91-9. PubMed ID: 20809502
[TBL] [Abstract][Full Text] [Related]
10. High content of Langerhans cells in malignant lymphoma--incidence and significance.
Benharroch D; Guterman G; Levy I; Shaco-Levy R
Virchows Arch; 2010 Jul; 457(1):63-7. PubMed ID: 20473767
[TBL] [Abstract][Full Text] [Related]
11. Unresolved issues concerning Hodgkin's disease and its relationship to non-Hodgkin's lymphoma.
Variakojis D; Anastasi J
Am J Clin Pathol; 1993 Apr; 99(4):436-44. PubMed ID: 8475910
[No Abstract] [Full Text] [Related]
12. T-cell neoplasms and Hodgkin's disease.
Cossman J
Monogr Pathol; 1987; (29):104-23. PubMed ID: 2884560
[No Abstract] [Full Text] [Related]
13. Glioma-associated oncogene homologue 3, a hedgehog transcription factor, is highly expressed in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.
Greaves WO; Kim JE; Singh RR; Drakos E; Kunkalla K; Sánchez-Espiridión B; Garcia JF; Medeiros LJ; Vega F
Hum Pathol; 2011 Nov; 42(11):1643-52. PubMed ID: 21531006
[TBL] [Abstract][Full Text] [Related]
14. Next-generation sequencing discoveries in lymphoma.
Slack GW; Gascoyne RD
Adv Anat Pathol; 2013 Mar; 20(2):110-6. PubMed ID: 23399796
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin gene rearrangement analysis in composite hodgkin disease and large B-cell lymphoma: evidence for receptor revision of immunoglobulin heavy chain variable region genes in Hodgkin-Reed-Sternberg cells?
Bellan C; Lazzi S; Zazzi M; Lalinga AV; Palummo N; Galieni P; Marafioti T; Tonini T; Cinti C; Leoncini L; Pileri SA; Tosi P
Diagn Mol Pathol; 2002 Mar; 11(1):2-8. PubMed ID: 11854595
[TBL] [Abstract][Full Text] [Related]
16. An illuminating piece in the jigsaw of Hodgkin lymphoma risk stratification.
Shankar A; Bomanji J
Br J Haematol; 2023 Jun; 201(6):1021-1022. PubMed ID: 36928799
[TBL] [Abstract][Full Text] [Related]
17. A gene expression-based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma.
Johnston RL; Mottok A; Chan FC; Jiang A; Diepstra A; Visser L; Telenius A; Gascoyne RD; Friedman DL; Schwartz CL; Kelly KM; Scott DW; Horton TM; Steidl C
Blood; 2022 Feb; 139(6):889-893. PubMed ID: 34662378
[TBL] [Abstract][Full Text] [Related]
18. Flow-cytometric DNA analysis in the diagnosis and prognosis of lymphoma.
Braylan RC
Am J Clin Pathol; 1993 Apr; 99(4):374-80. PubMed ID: 8475902
[No Abstract] [Full Text] [Related]
19. [Specifics of histopathological and genetical diagnosis and classification of lymphomas in children and adolescents].
Klapper W; Oschlies I
Klin Padiatr; 2012 Apr; 224(3):183-90. PubMed ID: 22513791
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma.
Admirand JH; Rassidakis GZ; Abruzzo LV; Valbuena JR; Jones D; Medeiros LJ
Mod Pathol; 2004 Aug; 17(8):954-61. PubMed ID: 15133473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
